CurrentCardio
Get Weekly

Topic · page 17 of 28

Coronary disease & ACS

Acute and chronic coronary syndromes, MI, INOCA/ANOCA, revascularisation strategy, antithrombotic therapy after ACS/PCI, chest-pain diagnostics

Briefs 641–680 of 1,104 placed here, newest publication first

Briefs in Coronary disease & ACS

Newest publication first

  1. JACC Heart Fail

    Mineralocorticoid Receptor Antagonists in Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Trials

    Meta-analysis

  2. Eur Heart J

    Radial vs femoral access for percutaneous coronary intervention: temporal trends and outcomes in the USA

    Cohort study

  3. Eur Heart J

    First myocardial infarction: risk factors, symptoms, and medical therapy

    Cohort study

  4. JAMA Cardiol

    Intracoronary Structural-Molecular Imaging for Multitargeted Characterization of High-Risk Plaque: First-in-Human OCT-FLIm

    Diagnostic or prognostic study

  5. JAMA Cardiol

    OCT vs Angiography for Guidance of Percutaneous Coronary Intervention of Calcified Lesions: The CALIPSO Randomized Clinical Trial

    Randomised controlled trial

  6. Eur J Prev Cardiol

    The ACS EuroPath survey series: time trends in lipid management after an acute coronary syndrome

    Cross-sectional study

  7. J Am Coll Cardiol

    Relationship Between Exercise-Induced Cardiac Troponin Elevations and Occult Coronary Atherosclerosis in Middle-Aged Athletes

    Cross-sectional study

  8. Circulation

    Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy

    Secondary analysis

  9. JACC Cardiovasc Interv

    Cost-Effectiveness of Early Discharge (<48 Hours) for Low-Risk Patients Following PPCI for STEMI

    Cohort study

  10. Eur J Prev Cardiol

    Comparative efficacy of LDL-C-lowering therapies in first-time vs. recurrent myocardial infarction prevention: a meta-analysis of large-scale randomized controlled trials

    Meta-analysis

  11. Eur J Prev Cardiol

    Sex differences in medication adherence and medication-associated mortality after coronary artery bypass grafting

    Cohort study

  12. JACC Cardiovasc Interv

    Procedural Impact of Advanced Calcific Plaque Modification Devices Within Percutaneous Revascularization of Chronic Total Occlusions

    Cohort study

  13. Eur J Prev Cardiol

    The presence or absence of standard modifiable cardiovascular risk factors in patients with myocardial infarction impacts long-term but not 30-day mortality: a UK Biobank prospective cohort study

    Cohort study

  14. JACC Cardiovasc Interv

    Aspirin vs Clopidogrel 1 Month After Acute Coronary Syndrome With High-Bleeding Risk or ST-Segment Elevation

    Secondary analysis

  15. BMJ

    P2Y 12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials

    Meta-analysis

  16. Circulation

    Joint Exposure to Ozone and Temperature and Acute Myocardial Infarction Among Adults Aged 18 to 64 Years in the United States

    Meta-analysis

  17. Eur J Prev Cardiol

    Association of longitudinal triglyceride levels with cardiovascular events in multivessel coronary artery disease

    Cohort study

  18. Eur Heart J

    Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial

    Randomised controlled trial

  19. JACC CardioOncol

    Risk of Hematologic Malignancies in Patients With Acute Myocardial Infarction: A Nationwide Population-Based Cohort Study

    Cohort study

  20. JACC Cardiovasc Interv

    Revascularization Strategies in ST-Segment Elevation Myocardial Infarction With Multivessel Disease: Temporal Trends, Patient Profiles, and Outcomes

    Cohort study

  21. Eur Heart J

    Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AβYSS trial

    Secondary analysis

  22. J Am Coll Cardiol

    Biolimus-Eluting Biomatrix Stent vs a Dual-Therapy Sirolimus-Eluting Stent in PCI: The SORT OUT XI Randomized Trial

    Randomised controlled trial

  23. Eur J Prev Cardiol

    Football as the champion of cardiovascular prevention: results of the randomized and interventional MY-3F study (Fit & Fun with Football after myocardial infarction or coronary artery disease)

    Randomised controlled trial

  24. Eur Heart J

    Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis

    Guideline or statement

  25. J Am Coll Cardiol

    10-Year Outcome of Complete or Infarct Artery-Only Revascularization in STEMI With Multivessel Disease: The DANAMI-3-PRIMULTI Study

    Secondary analysis

  26. Eur Heart J

    Coronary artery bypass grafting with or without preoperative physiological stenosis assessment: a SWEDEHEART study

    Cohort study

  27. J Am Coll Cardiol

    Ischemia on Dobutamine Stress Echocardiography Predicts Efficacy of PCI: Results From the ORBITA-2 Trial

    Secondary analysis

  28. JACC Cardiovasc Interv

    Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion With Bifurcation at Distal Cap

    Cohort study

  29. Eur J Heart Fail

    Mitochondrial Targets in Ischaemic Heart Disease and Heart Failure, and their Potential for a More Efficient Clinical Translation. A Scientific Statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function

    Guideline or statement

  30. Eur Heart J

    Colchicine for secondary prevention of vascular events: a meta-analysis of trials

    Meta-analysis

  31. J Am Coll Cardiol

    2025 AHA/ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance Measures

    Guideline or statement

  32. Eur J Prev Cardiol

    Long-term fine particulate matter exposure and coronary artery disease: unravelling cardiometabolic pathways and modification of genetic susceptibility

    Cohort study

  33. Eur J Prev Cardiol

    Effectiveness of coronary heart disease peer support interventions: a systematic review and meta-analysis

    Meta-analysis

  34. Eur Heart J

    Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium

    Guideline or statement

  35. JACC Cardiovasc Imaging

    Prognostic Time Frame of Plaque and Hemodynamic Characteristics and Integrative Risk Prediction for Acute Coronary Syndrome

    Cohort study

  36. JACC Cardiovasc Interv

    Association Between Myocardial Infarction and Quality of Life in the ISCHEMIA Trial

    Secondary analysis

  37. JACC Cardiovasc Interv

    Proportion and Clinical Impact of Stent Optimization During Imaging-Guided Percutaneous Coronary Intervention: The OCTIVUS Trial

    Secondary analysis

  38. JACC Cardiovasc Interv

    Factors Associated With Chronic Stent Recoil and its Impact on Revascularization: A Serial Optical Coherence Tomography Study

    Cohort study

  39. J Am Coll Cardiol

    Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry

    Cohort study

  40. Eur J Prev Cardiol

    Prognostic impact of reduced kidney function in patients with suspected coronary artery disease undergoing CCTA

    Cohort study

All 1,104 Briefs in ExploreShowing Briefs 641–680 of 1,104, newest first